P. Rebello

Phase I study of an engineered aglycosylated humanized CD3 antibody in renal transplant rejection.

J. Phillips, J. Bradley, J. Bradley, 1999, Transplantation.

Alemtuzumab (CAMPATH-1H) for the Treatment of Acute Rejection in Kidney Transplant Recipients: Long-Term Follow-Up

M. Clatworthy, P. Friend, G. Hale, 2009, Transplantation.

Immunosuppression of canine renal allograft recipients by CD4 and CD8 monoclonal antibodies.

S. Metcalfe, P. Rebello, S. Thiru, 1994, Tissue antigens.

A simple method for measuring patient anti-globulin responses against isotypic or idiotypic determinants.

P. Friend, P. Rebello, S. Cobbold, 1990, Journal of immunological methods.

Anti-globulin responses to rat and humanized CAMPATH-1 monoclonal antibody used to treat transplant rejection.

P. Friend, G. Hale, P. Rebello, 1999, Transplantation.

Reversal of allograft rejection using the monoclonal antibody, Campath-1G.

P. Friend, G. Hale, P. Rebello, 1991, Transplantation proceedings.

Successful treatment of renal allograft rejection with a humanized antilymphocyte monoclonal antibody.

P. Friend, P. Rebello, R. Calne, 1995, Transplantation proceedings.